|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Whole-of-Community Systems Intervention for Youth Population Physical Activity
|
1R01CA215420-01A1
|
$512,891
|
|
DZEWALTOWSKI, DAVID
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-05
|
$1,394,352
|
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and Progestins for the Chemoprevention of Fallopian Tube/Ovarian Cancer
|
1R01CA214606-01A1
|
$370,707
|
|
RODRIGUEZ, GUSTAVO
|
NORTHSHORE UNIVERSITY HEALTHSYSTEM
|
|
Vascular communication in metastatic brain colonization
|
5R01CA184594-05
|
$321,625
|
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-05
|
$644,932
|
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-05
|
$768,950
|
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Uncertainties in Radiomics Studies
|
5R21CA216572-02
|
$139,200
|
|
COURT, LAURENCE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Understanding the role of ?B-Ras proteins in tumorigenesis
|
5R01CA206556-03
|
$384,782
|
|
GHOSH, SANKAR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Understanding and Improving Platinum Anticancer Drugs
|
5R01CA034992-36
|
$674,719
|
|
YILMAZ, OMER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Uncovering the role of individual RNA helicases in cancer through specific chemical inhibition
|
5F30CA203522-03
|
$49,524
|
|
BARKOVICH, KRISTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
UM LAPs- U10 Grant
|
5U10CA180801-05
|
$763,048
|
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells
|
5R21CA212958-02
|
$216,000
|
|
KESHARI, KAYVAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-05
|
$623,007
|
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor-stromal interactions as targets of tumor metastasis suppressors
|
5R01CA184494-04
|
$350,689
|
|
ROSNER, MARSHA
|
UNIVERSITY OF CHICAGO
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$195,669
|
$37,177
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor heterogeneity in breast cancer brain metastasis after brain radiation
|
ZIA BC 011330
|
$140,734
|
$70,367
|
Smart, DeeDee
|
CCR (NCI)
|
|
Treatment of glioma with nanocombretastatin with MRI monitoring
|
5R01CA206190-03
|
$344,269
|
|
ALI, MESER
|
Henry Ford Health System
|
|
Translation addiction and targeting in colon cancer
|
1R01CA215481-01A1
|
$467,690
|
|
YU, JIAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents
|
5R01CA172576-05
|
$319,550
|
|
CLINTON, STEVEN
|
OHIO STATE UNIVERSITY
|
|
Transcriptional Regulation of Immunosuppressive Macrophages by c-Maf in Cancer
|
5R01CA213990-02
|
$352,275
|
|
YAN, JUN
|
UNIVERSITY OF LOUISVILLE
|
|
Transcriptional CDKs as therapeutic targets in MYC-dependent cancers
|
5R01CA197336-03
|
$407,748
|
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
Transcription repression in prostate cancer
|
5R01CA112226-09
|
$402,563
|
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Towards the automation of MR spectroscopic imaging in patients with glioblashoma
|
5F30CA206291-03
|
$49,524
|
|
GURBANI, SAUMYA
|
EMORY UNIVERSITY
|
|
Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis
|
1K08CA222625-01
|
$177,372
|
|
OKIMOTO, ROSS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The Synergy Between Radiotherapy and Molecularly Targeted Agents
|
ZIA SC 010373
|
$1,227,708
|
$982,166
|
Camphausen, Kevin
|
CCR (NCI)
|
|
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma
|
ZIA BC 011017
|
$882,117
|
$882,117
|
Van Dyke, Terry
|
CCR (NCI)
|
|
The Role of STAT2 in Flat Non-Polypoid Colorectal Neoplasia
|
5R03CA215929-02
|
$78,000
|
|
GAMERO, ANA
|
TEMPLE UNIV OF THE COMMONWEALTH
|
|
The role of PRAME in promoting metastasis in uveal melanoma
|
5F30CA206430-03
|
$49,524
|
|
FIELD, MATTHEW
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
The Role of miRNAs in Glioma Stem Cell and Glioma Biology
|
ZIA BC 011102
|
$536,416
|
$536,416
|
Fine, Howard
|
CCR (NCI)
|
|
The Role of LIN28B Signaling in Mediating the Oncogenic Phenotype in Neuroblas
|
5K08CA194162-04
|
$168,264
|
|
SCHNEPP, ROBERT
|
EMORY UNIVERSITY
|
|
The Role of JAK2 in ILEI-Induced Cancer Stem Cell Formation
|
5F30CA203269-03
|
$46,154
|
|
NOGUCHI, KEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
The Role of DLST in Leukemogenesis
|
1R01CA215059-01A1
|
$377,437
|
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The role of deubiquitinating enzyme USP33 in Slit-Robo signaling in lung cancer
|
5R01CA175360-05
|
$442,825
|
|
WU, JANE
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma
|
5R01CA182869-04
|
$345,918
|
|
HOUCHEN, COURTNEY
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
The role of CREB3L1 in synergy between oncolytic vaccinia virus and doxorubicin
|
1R03CA223623-01
|
$85,900
|
|
KOZBOR, DANUTA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
The Role of Cellular Receptors Involved in Inflammation and Tumor Progression
|
ZIA BC 010015
|
$328,101
|
$246,075
|
Wang, Ji Ming
|
CCR (NCI)
|
|
The role of AXL-ABL axis in Barretts carcinogenesis
|
5R01CA193219-04
|
$361,425
|
|
BELKHIRI, ABBES
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
The Paradoxical Role of mTORC1 in the Growth of Nutrient-deprived Pancreatic Cancer Cells Harboring Ras Mutations
|
5R01CA201318-03
|
$339,879
|
|
THOMPSON, CRAIG
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The Myc - miR-17-92 axis in colorectal cancers
|
5R01CA196299-04
|
$384,300
|
|
THOMAS-TIKHONENKO, ANDREI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma
|
1R01CA216922-01A1
|
$426,489
|
|
HENSKE, ELIZABETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The mechanical and biochemical mechanism of oncogenic Rac1P29S mutation in melanoma survival signaling
|
5F30CA206399-02
|
$33,199
|
|
MOHAN, ASHWATHI
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The Invisible Phosphoproteome: New Tools to Study Histidine Phosphorylation
|
5R01CA194584-04
|
$443,775
|
|
HUNTER, TONY
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
The Impact of Tobacco Control Policies on Health Equity in the United States
|
1R37CA214787-01A1
|
$518,400
|
|
FLEISCHER, NANCY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The Glioma Molecular Diagnostic Initiative: Characterizing Brain Tumor Data
|
ZIA SC 010100
|
$469,364
|
$469,364
|
Fine, Howard
|
CCR (NCI)
|
|
The Genetic Architecture of Breast Parenchymal Textural Features and its Implications for Breast Cancer Risk
|
1R03CA224196-01
|
$79,750
|
|
JIANG, XIA
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
The Clinical PET Imaging of Metastatic Breast Cancer with Site-Specifically Labeled 89Zr-Trastuzumab
|
5R01CA204167-03
|
$674,466
|
|
LEWIS, JASON
|
SLOAN-KETTERING INST CAN RESEARCH
|
Total relevant funding to Nervous System for this search: $32,061,943
|